CHICAGO, Sept. 24 /PRNewswire/ -- Diamond Management & Technology Consultants, Inc. (Nasdaq: DTPI) announced today that Richard Findlay, whose experience includes senior executive positions at SmithKline Beecham and Abbott Laboratories, has joined the firm as a partner in its healthcare practice.
Findlay has 25 years of experience in both managing and consulting to life science companies including pharmaceuticals, biotech, medical device, consumer health, and payors. His portfolio of expertise spans the value chain of operations with a particular focus on sales and marketing, supply chain, and clinical development. In addition, he served as President and CEO of RxCentric, a leading provider of technology-enabled sales and marketing solutions for the pharmaceutical industry that was later acquired by Allscripts Healthcare Solutions.
Findlay, a resident of suburban Philadelphia, speaks and writes frequently on topics in the Pharmaceutical industry in addition to teaching on the Adjunct faculty at Saint Joseph's University, Philadelphia, and at the Wharton School of Business at the University of Pennsylvania. He received his Bachelor's of Science with Honors in Chemistry at the University of Exeter in England and qualified as a Management Accountant in the United Kingdom.
"Richard has an impressive breadth of experience in helping healthcare companies address the challenges they face at the intersection of business and technology," said Adam Gutstein, Diamond's President and CEO. "He has the strategy and execution experience required to help clients implement complex initiatives, improve their profitability and increase revenue and market share."
Diamond's Healthcare practice works with leading pa
'/>"/>
| SOURCE Diamond Management & Technology Consultants, Inc. Copyright©2007 PR Newswire. All rights reserved |